19th Aug 2020 11:09
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 18 August 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,512,098 | 1.17% | 472,431 | 0.37% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
355,000 | 0.28% | 383,659 | 0.30% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,867,098 | 1.45% | 856,090 | 0.66% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 2 | 200.0100 USD |
Purchase | 2 | 202.1300 USD |
Purchase | 5 | 201.8700 USD |
Purchase | 20 | 201.0000 USD |
Purchase | 26 | 202.0000 USD |
Purchase | 71 | 200.9367 USD |
Purchase | 100 | 201.0200 USD |
Purchase | 100 | 201.9400 USD |
Purchase | 140 | 201.5621 USD |
Purchase | 172 | 201.3855 USD |
Purchase | 200 | 201.2750 USD |
Purchase | 300 | 202.5400 USD |
Purchase | 300 | 201.9866 USD |
Purchase | 567 | 201.9231 USD |
Purchase | 576 | 200.8854 USD |
Purchase | 700 | 201.4508 USD |
Purchase | 2,915 | 201.4355 USD |
Purchase | 3,055 | 201.4413 USD |
Purchase | 4,854 | 201.3100 USD |
Purchase | 6,949 | 200.9376 USD |
Purchase | 18,730 | 201.8247 USD |
Purchase | 128,269 | 201.2012 USD |
Purchase | 128,269 | 201.2013 USD |
Sale | 2 | 200.0100 USD |
Sale | 7 | 201.9442 USD |
Sale | 11 | 201.9800 USD |
Sale | 38 | 201.4400 USD |
Sale | 70 | 201.3800 USD |
Sale | 71 | 200.9367 USD |
Sale | 76 | 202.9000 USD |
Sale | 78 | 202.1900 USD |
Sale | 100 | 201.5600 USD |
Sale | 100 | 200.9800 USD |
Sale | 100 | 202.0800 USD |
Sale | 101 | 202.0906 USD |
Sale | 200 | 201.9600 USD |
Sale | 200 | 201.6950 USD |
Sale | 200 | 201.8000 USD |
Sale | 200 | 201.2750 USD |
Sale | 300 | 201.7500 USD |
Sale | 304 | 201.6313 USD |
Sale | 318 | 201.2988 USD |
Sale | 400 | 201.5837 USD |
Sale | 410 | 201.7295 USD |
Sale | 600 | 201.7483 USD |
Sale | 601 | 201.7283 USD |
Sale | 946 | 201.0173 USD |
Sale | 1,127 | 201.7060 USD |
Sale | 1,143 | 202.2355 USD |
Sale | 1,199 | 201.7008 USD |
Sale | 1,440 | 201.5261 USD |
Sale | 1,501 | 200.5450 USD |
Sale | 1,615 | 201.3656 USD |
Sale | 1,625 | 201.4971 USD |
Sale | 1,930 | 201.6832 USD |
Sale | 2,568 | 201.1154 USD |
Sale | 2,819 | 201.0692 USD |
Sale | 2,855 | 201.4235 USD |
Sale | 3,603 | 200.9510 USD |
Sale | 3,620 | 200.9622 USD |
Sale | 3,910 | 200.9970 USD |
Sale | 4,147 | 201.3100 USD |
Sale | 4,472 | 200.9455 USD |
Sale | 4,772 | 201.1720 USD |
Sale | 7,219 | 201.0636 USD |
Sale | 7,583 | 201.2145 USD |
Sale | 8,864 | 201.1637 USD |
Sale | 10,379 | 201.1308 USD |
Sale | 16,869 | 201.7932 USD |
Sale | 66,705 | 201.2434 USD |
Sale | 128,269 | 201.2012 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
| Full details of any agreement, arrangement or understanding between the person disclosing |
| and any other person relating to the voting rights of any relevant securities under any option |
| referred to on this form or relating to the voting rights or future acquisition or disposal of any |
| relevant securities to which any derivative referred to on this form is referenced. If none, this |
| should be stated. |
| NONE |
Is a Supplemental Form 8 attached? (Note 9) YES/NO
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 19 Aug 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20200819005299/en/
Copyright Business Wire 2020
Related Shares:
Barclays